CLIPI and Risk Stratification in Advanced Mycosis Fungoides and Sézary Syndrome

Дата публикации: 07-10-2026 00:00:00

This cohort study assesses whether the Cutaneous Lymphoma International Prognostic Index may be used to predict progression-free survival and best objective response in patients with advanced mycosis fungoides or Sézary syndrome.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Improved Risk Stratification in Mycosis Fungoides and Sézary Syndrome	0	8.93	07-10-2026
2	MAIBE for Patients With Locally Advanced Pancreatic Cancer	0	5.92	01-09-2026
3	Inflation-Adjusted Medicare Reimbursement for Common Dermatologic Procedures	0	23.01	07-10-2026
4	Pseudofolliculitis Barbae Diagnosis and Treatment in US Veterans	0	8.06	30-09-2026
5	Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer	0	6.4	01-09-2026
6	Lumpectomy Margins and Local Recurrence in DCIS	0	8.55	01-09-2026
7	Generalized Linear Keratotic Papules in a Man in His 30s	0	6.38	30-09-2026
8	BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus	0	28.92	30-09-2026
9	EADV: Autonomous AI Can Increase Clinical Capacity for Dermatologists	0	9.51	06-10-2026
10	Cardiovascular Disease Risk Among Childhood and Young Adult Cancer Survivors	0	3.87	28-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.48. Источник: archderm.jamanetwork.com.